Genmab

About:

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.

Website: https://www.genmab.com

Twitter/X: genmab

Top Investors: Index Ventures, GlaxoSmithKline, Apax Partners Development, Dansk Erhvervsinvestering, LODH Immunology Fund

Description:

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.

Total Funding Amount:

$204M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Copenhagen, Hovedstaden, Denmark

Founded Date:

1999-01-01

Contact Email:

info(AT)genmab.com

Founders:

Don Drakeman, Jan van de Winkel

Number of Employees:

501-1000

Last Funding Date:

2010-07-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai